NO994049D0 - Metode for å fremstille farmasöytiske forbindelser - Google Patents

Metode for å fremstille farmasöytiske forbindelser

Info

Publication number
NO994049D0
NO994049D0 NO994049A NO994049A NO994049D0 NO 994049 D0 NO994049 D0 NO 994049D0 NO 994049 A NO994049 A NO 994049A NO 994049 A NO994049 A NO 994049A NO 994049 D0 NO994049 D0 NO 994049D0
Authority
NO
Norway
Prior art keywords
pharmaceutical compounds
preparing pharmaceutical
preparing
compounds
pharmaceutical
Prior art date
Application number
NO994049A
Other languages
English (en)
Norwegian (no)
Other versions
NO994049L (no
Inventor
David W Hoard
Eric D Moher
Vinod Francis Patel
Original Assignee
Lilly Co Eli
Univ Hawaii
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Univ Hawaii, Univ Wayne State filed Critical Lilly Co Eli
Publication of NO994049L publication Critical patent/NO994049L/no
Publication of NO994049D0 publication Critical patent/NO994049D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/46Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by amide or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
NO994049A 1997-02-26 1999-08-23 Metode for å fremstille farmasöytiske forbindelser NO994049D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3911497P 1997-02-26 1997-02-26
US3911697P 1997-02-26 1997-02-26
PCT/US1998/003655 WO1998038158A1 (en) 1997-02-26 1998-02-25 Process for preparing pharmaceutical compounds

Publications (2)

Publication Number Publication Date
NO994049L NO994049L (no) 1999-08-23
NO994049D0 true NO994049D0 (no) 1999-08-23

Family

ID=26715826

Family Applications (2)

Application Number Title Priority Date Filing Date
NO994049A NO994049D0 (no) 1997-02-26 1999-08-23 Metode for å fremstille farmasöytiske forbindelser
NO994083A NO994083L (no) 1997-02-26 1999-08-24 Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO994083A NO994083L (no) 1997-02-26 1999-08-24 Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelser

Country Status (17)

Country Link
US (1) US6143909A (cs)
EP (2) EP0861838A3 (cs)
JP (2) JP2002513403A (cs)
KR (2) KR20000075671A (cs)
CN (2) CN1252788A (cs)
AU (2) AU6667198A (cs)
BR (2) BR9807265A (cs)
CA (2) CA2281104A1 (cs)
CZ (1) CZ9902998A3 (cs)
EA (2) EA199900770A1 (cs)
ID (2) ID24527A (cs)
IL (2) IL131162A0 (cs)
NO (2) NO994049D0 (cs)
NZ (1) NZ336918A (cs)
PL (2) PL335347A1 (cs)
TR (2) TR199902064T2 (cs)
WO (2) WO1998038158A1 (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001500484A (ja) * 1996-08-30 2001-01-16 イーライ・リリー・アンド・カンパニー 医薬化合物の製造法
JP2001506970A (ja) * 1996-09-06 2001-05-29 イーライ・リリー・アンド・カンパニー 方法及び新規な中間体
AU1123200A (en) * 1998-10-16 2000-05-08 Eli Lilly And Company Stereoselective process for producing antineoplastic agents
WO2000034253A2 (en) * 1998-12-07 2000-06-15 Eli Lilly And Company Intermediates and reaction sequence to produce said intermediates useful for the preparation of antineoplastic and antifungal cryptophycin derivatives
WO2000034252A2 (en) * 1998-12-07 2000-06-15 Eli Lilly And Company Process for the preparation of cryptophycin derivatives
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
EP1751279A4 (en) * 2004-05-05 2008-03-19 Univ Minnesota NUCLEIC ACIDS AND POLYPEPTIDES INVOLVED IN THE PREPARATION OF CRYPTOPHYCIN
CN101962323B (zh) * 2010-07-16 2013-06-05 中国人民解放军第二军医大学 2-丙烯酰x基-3-取代苯基丙酸类化合物及其用途
CN111333560B (zh) * 2020-04-13 2024-01-23 合肥工业大学 一种制备螺环β-内酰胺的方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946835A (en) * 1988-07-15 1990-08-07 Merck & Co., Inc. Antifungal fermentation product and method
US4868208A (en) * 1988-07-15 1989-09-19 Merck & Co., Inc. Antifungal agent and method
US4845085A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
US4845086A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
CA2047191A1 (en) * 1989-02-17 1990-08-18 Hendrik M. Geysen Method for the use and synthesis of peptides
US5256802A (en) * 1990-04-03 1993-10-26 Miles Inc. Process for the production of oxiranes
HUT73150A (en) * 1992-11-06 1996-06-28 Chiron Mimotopes Pty Ltd Modular polymer and support for the synthesis thereof
GB2282384B8 (en) * 1993-08-18 1997-09-04 Europ Economic Community Drug delivery agents incorporating mitomycin
WO1995017093A1 (en) * 1993-12-21 1995-06-29 University Of Hawaii New cryptophycins
US5952298A (en) * 1993-12-21 1999-09-14 The University Of Hawaii Cryptophycins
ATE191917T1 (de) * 1994-10-14 2000-05-15 Stratagene Inc Porphyrin-markierung von polynukleotiden
MD2196B2 (ro) * 1995-03-07 2003-06-30 Юнивэсити Эв Хауайи Criptoficine, procedeu de obţinere, compoziţii farmaceutice pe baza acestora, metodă de inhibare a proliferării celulelor mamiferelor şi metodă de atenuare a stării patologice cauzate de hiperproliferarea celulelor mamiferelor
CA2217051C (en) * 1995-03-31 2006-05-30 Nippon Chemiphar Co., Ltd. Epoxysuccinic acid derivatives
US5700826A (en) * 1995-06-07 1997-12-23 Ontogen Corporation 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance
JP2000501067A (ja) * 1995-08-30 2000-02-02 イーライ・リリー・アンド・カンパニー 医薬化合物
CA2241086A1 (en) * 1995-12-22 1997-07-03 University Of Hawai'i Pharmaceutical compounds
US5843865A (en) * 1996-02-07 1998-12-01 Buckman Laboratories International, Inc. Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same
DE69704731D1 (de) * 1996-02-27 2001-06-13 Lilly Co Eli Cryptophycinderivate und ihre Verwendung als antimikrotubuli Mittel
JP2001502297A (ja) * 1996-08-30 2001-02-20 イーライ・リリー・アンド・カンパニー 医薬用化合物
IL128610A (en) * 1996-08-30 2004-07-25 Lilly Co Eli Cryptophycin compound and its use as a medicament for treating neoplasm
JP2001500853A (ja) * 1996-08-30 2001-01-23 イーライ・リリー・アンド・カンパニー 医薬化合物
US6025506A (en) * 1997-02-21 2000-02-15 Dsm N.V. Process for preparing an optically active phenylglycidyl acid derivative
IL123352A0 (en) * 1997-02-27 1998-09-24 Tanabe Seiyaku Co Process for preparing an optically active trans-3-substituted glycidic acid ester

Also Published As

Publication number Publication date
AU6667198A (en) 1998-09-18
NO994049L (no) 1999-08-23
PL335478A1 (en) 2000-04-25
ID22984A (id) 1999-12-23
JP2002512603A (ja) 2002-04-23
NZ336918A (en) 2001-11-30
EA199900772A1 (ru) 2000-04-24
KR20000075671A (ko) 2000-12-26
IL131205A0 (en) 2001-01-28
PL335347A1 (en) 2000-04-25
NO994083L (no) 1999-10-25
TR199902064T2 (xx) 2001-10-22
CN1255121A (zh) 2000-05-31
EP0861838A3 (en) 1998-12-09
KR20000075623A (ko) 2000-12-26
TR199902065T2 (xx) 2000-02-21
WO1998038164A1 (en) 1998-09-03
EA002547B1 (ru) 2002-06-27
EP0861839A1 (en) 1998-09-02
EA199900770A1 (ru) 2000-04-24
AU738999B2 (en) 2001-10-04
CZ9902998A3 (cs) 2002-10-16
NO994083D0 (no) 1999-08-24
ID24527A (id) 2000-07-20
WO1998038158A1 (en) 1998-09-03
IL131162A0 (en) 2001-01-28
AU6667298A (en) 1998-09-18
CA2281104A1 (en) 1998-09-03
BR9811252A (pt) 2000-09-26
CA2281108A1 (en) 1998-09-03
JP2002513403A (ja) 2002-05-08
US6143909A (en) 2000-11-07
EP0861838A2 (en) 1998-09-02
BR9807265A (pt) 2000-05-23
CN1252788A (zh) 2000-05-10

Similar Documents

Publication Publication Date Title
FI973518A (fi) Farmaseuttinen koostumus piperidinoalkanoliyhdisteille
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
NO994757L (no) Fremgangsmåte for oral administrasjon av proteiner
NO995681D0 (no) Fremgangsmåte for å fremstille fluorbiprofen-tabletter
AR017655A1 (es) Metodo para preparar eteres de monofluormetilo
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
BR9610214A (pt) Compostos farmacéuticos
NO974169D0 (no) Fremgangsmåte for tetra-azacykloalkan-fremstilling
NO20001728D0 (no) Fremgangsmåte for fremstilling av chirale forbindelser
ID28601A (id) Proses penyiapan senyawa-senyawa 1,4-dihidropiridin
IT1272922B (it) Procedimento per la preparazione di composti metallocenici
NO994049D0 (no) Metode for å fremstille farmasöytiske forbindelser
ID22840A (id) Proses untuk penyiapan komposisi aspal
NO995851D0 (no) Fremstillingsfremgangsmåte for isoksasolidinedion forbindelse
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
EE9800195A (et) Uudsed analgeetilise toimega ühendid
NO20001777D0 (no) Fremgangsmåte for fremstilling av substituerte 4-fenyl-4- cyanocykloheksankarboksylsyrer
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
ID22430A (id) Proses pembuatan senyawa-senyawa benzotiazolona
NO993863D0 (no) Forbindelser og fremgangsmåte for fremstilling av substituerte 4-fenyl-4-cyanocycloheksansyrer
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
NO965448L (no) Farmasöytiske forbindelser
NO20003145D0 (no) FremgangsmÕte for fremstilling av paroxetine-hydroklorid
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
EG21226A (en) Process for preparing of new pharmaceutical compound

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application